It combines Olmesartan Medoxomil, an angiotensin II receptor blocker (ARB), with Amlodipine, a calcium channel blocker that relaxes blood vessels and improves blood circulation
None of these compounds has undergone a Phase 3 randomized controlled trial in humans that would support an FDA drug approval claim
Individuals with known copper sensitivity should avoid GHK-Cu
Description GHK-Cu Peptide GHK-Cu is a naturally occurring complex molecule composed of a tripeptide called GHK (made up of glycine, histidine, and lysine amino acids) bound to a copper ion
Your provider should review your complete medical history and relevant biomarkerssuch as liver function tests, oxidative stress markers, and antioxidant enzyme activitybefore recommending a specific dose
AHK-Cu, with its alanine residue, may exhibit improved skin penetration due to its slightly more lipophilic nature